SLC5A2 and type 2 diabetes mellitus: A recent study investigating the effect of SGLT2 inhibition on scRNA-Seq data in kidney biopsies of patients with youth-onset T2D found suppression of glycolytic gene expression with treatment, including aldolase B and phosphofructokinase (27).